SUBSCRIBE
SUBSCRIBE
News   Business

Innovata plc In Anti-Adhesion Drug Deal With Baxter International, Inc.

January 3, 2006 | 
1 min read
LONDON, Jan 3 (Reuters) - Innovata Plc said on Tuesday it had agreed a global licensing deal with Baxter International over its treatment for adhesions, or internal scarring, in abdominal, obstetric and gynaecologic surgery.
Alliances Europe
Baxter International, Inc.
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Alltrna’s Clinical Acceleration Aims Leave 35% of Staff Behind
March 6, 2026
 · 
31 min read
 · 
BioSpace Editorial Staff
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
March 5, 2026
 · 
2 min read
 · 
Heather McKenzie
Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.
Collaboration
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge
March 5, 2026
 · 
1 min read
 · 
Tristan Manalac
Podcast
UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More
March 4, 2026
 · 
1 min read
 · 
Heather McKenzie